Prof. Dr. Cornelia Kasper, University of Natural Resources and Life Sciences, Vienna (BOKU), Department of Biotechnology Cornelia Kasper studied Chemistry at the University of Hanover and received her Diploma degree in 1994. She graduated from the Institute of Technical Chemistry in 1995-1998 and graduated as Ph.D. rer. nat .. Until 2000 she was employed as EU liaison officer at the University of Hannover. Afterwards she received a habilitation fellowship from the University of Hannover 2000-2006. She finished her habilitation on "New Approaches in Cell Culture Techniques" and received the Venia Legendi "Technical Chemistry" (2007). 2000-2011 Cornelia Kasper has been head of the Cell Culture and Tissue Engineering Group at the Institute for Technical Chemistry, Leibniz University of Hannover. Tissue engineering, design and development of biomaterials for tissue engineering applications, development of procedures for stem cell isolation, characterization, expansion and differentiation. She is also head of young researcher group JRG "Large Scale Cultivation" within Cluster of Excellence "Rebirth" (from Regenerative Biology and Reconstructive Therapies). Since October 2011 Cornelia Kasper has been appointed Boku University Professor (§98) at the Department of Biotechnology and Head of Cell and Tissue Culture Technologies. The research group within the institute is on the development and optimization of processes and physiological cell culture conditions for the production of stem cells and products derived from stem cells. Tissue Engineering and Stem Cell Research within the series "Advances in Biochemical Engineering and Biotechnology" (Springer) as well as editor of textbooks within the series "Learning Materials" (Springer) on "Cell Culture Technology" and "Basic Concepts of 3 D Cell Culture". She is also reviewer for many distinguished journal within the field of biotechnology / bioprocess and bioreactor design and enabling technologies for stem cell cultivation and expert reviewer for national and international funding agencies and member of international societies within the field of Tissue Engineering and Regenerative Medicine.

Professor, Department of Cardiology - Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Degree-Granting Education. Honors & Awards 1978 Steps-Toward-Independence Fellowship, Marine Biological Laboratory 1975 Muscular Dystrophy Association Postdoctoral Fellowship, Muscular Dystrophy Association 1962 American Field Service (AFS) International Scholarship, American Field Service (AFS) 1974 University of Pennsylvania, Phildelphia, PA, USA, PHD, Biology, Program in Biophysical Cytology 1968 International Christian University, Mitaka, JPN, BA, Natural Sciences; Division of Biology

Prof. Avri Ben-Ze’ev studied at the Hebrew University of Jerusalem and received a Ph.D. in Virology. After conducting postdoctoral research at the Massachusetts Institute of Technology, he joined the staff of the Weizmann Institute of Science in 1979 where he was promoted to associate and full professor in 1999. Now, a member of the Molecular Cell Biology Department, he has been a visiting professor at Harvard University Medical School, Boston University Medical School, La Jolla Cancer Research Foundation, The Curie Institute in Paris and the Albert Einstein College of Medicine in NY. He is a member of several Israeli, American and international professional societies, including the American Society for Cell Biology, the American Association for Cancer Research, the Israel Society for Cell Biology and Molecular Biology, the New York Academy of Sciences and the International Agency Against Cancer (UICC), and serves as executive editor of the journal Molecular and Cellular Differentiation and as editor of the Journal of Cellular Biochemistry andthe International Journal of Cell Biology. Prof. Ben-Ze’ev studies genes and cellular mechanisms involved in cancer. His research focuses on beta-catenin, a gene that is abnormally activated in about 90 percent of colorectal cancer patients. Ben-Ze’ev has clarified how beta-catenin becomes hyperactive in cancerous cells and identified some of the signaling pathways unleashed by this gene in malignancy. His team has also revealed that beta-catenin is involved in key mechanisms leading to the metastasis of colon cancer cells, some of which are similar to mechanisms regulating colon stem cell biology. These studies could help design genetically based screening for early-stage colon cancer and develop target-specific therapy to prevent, or reverse, the metastatic spread of malignant tumors.

Dr. Alahari obtained his Bachelor of Science in Biology and Master of Science in Human Genetics from India in 1983 and 1986 respectively. His Ph.D. in Molecular Biology was awarded by Drexel University, Philadelphia in the year 1994. From 1994 to 1998, Dr. Alahari did a post-doctoral fellowship at the University of North Carolina at Chapel Hill. Since 1998, he has been a faculty member at the University of North Carolina and in 2004 joined the LSUHSC as Associate Professor of the Department of Biochemistry. During his tenure at the University of North Carolina, he discovered a novel protein that he termed, Nischarin. Dr. Alahari has published several papers describing the function of Nischarin. He has served on editorial review boards and study sections. In addition he availed visiting professorships at the University of Pennsylvania, Philadelphia and Rockefeller University, New York.

Dr. Chen conducts research in “translational bioinformatics”—the science of collecting, representing, storing, retrieving and processing data and knowledge for the improvement of human health. His research interest focus on systems biology, data mining, advanced visual analytics for therapeutic discovery and clinical decision-making applications. He has published more than 130 peer-reviewed scientific papers and edited two bioinformatics books, “Biological Database Modeling” and “Biological Data Mining”. He has organized many conferences, among which the BIOKDD workshop at the Annual ACM Knowledge Discovery and Data Mining Conference have been running consecutively for nearly two decades. He is a frequent grant review panelist for NIH, NSF, and DOD in bioinformatics. He was named a finalist as “Indiana’s Technology Educator of the Year” for his contribution to informatics research, education, and entrepreneurship in the state of Indiana.

Full name: PHAN PHUOC HIEN, Vietnamese Majors: Biochemistry Scientific function rank: Associate Professor in Biochemistry (2010) Current positions: (1) Director, Institute of Applied Science and Technology, Van Lang University HCMC, Vietnam (2) Director, Institute of Conservation and Development for Medicine Materials Saigon, HCMC Years of work experience: 1977-2020 (43 experience years) Education: - Postdoct in Agro-Industrial Chemistry (2001-2003): National Polytechnique Institute (INP) Toulouse France and Ecole National de Formation Agronomique (ENFA) Toulouse, France - Ph.D in Biochemistry (1996-2001): National Centre for Natural Sciences and Technology Viet nam/France & INP/ENFA/Paul Sabatier Toulouse France (combinative programme). Publications and Research projects: 160 works consisting of 139 National and International papers, 5 books, and 19 national and international scientific projects Current Research themes: - Bio-Pharmaco chemical technology, - Traditional and modern food processing technology. - Agricultural high Technology, - Medecine materials and drug preparation - Traditional and modern methods of extraction, separation, isolation, purification & crystallization to produce drug, biopesticide, botanical insecticides… - Analysis methods: Determination of molecular structure by Chromatography (GC, GCMS, HPLC. MS, LCMS…), X-ray diffraction… - Volatile compound qualification and quantification in aromatice rice, medicinal plant, tea, foodstuffs…by SDE/GC-GCMS, SPME-GCFID/GCMS… - Applied research on applications irradiation techniques to produce new materials, plant breeding, and prolong self-life for foods/foodstuffs, bio-fuel…. - Traditional and Modern fermentation technology to produce bio-products for use in food-stuff, functional food…

We will Update it soon

Melissa Mather carried out a Bachelor of Applied Science (Hons), majoring in physics, at the Queensland University of Technology (QUT), Brisbane, Australia. This was followed by a PhD (2003) studying the evaluation by ultrasound of radiation sensitive polymer gels, carried out in the Centre for Medical, Health and Environmental Physics at QUT. In May 2003 Melissa took up an appointment as research fellow in the Applied Ultrasonics research group in the School of Electrical and Electronic Engineering at the University of Nottingham. This post involved the development of ultrasonic techniques for characterisation of industrially relevant solid-in-liquid suspensions and the detection of phase transitions in supercritical fluids. In October 2005 Melissa was appointed as research fellow in the Applied Optics group as part of the 'remedi' EPSRC Grand Challenge in Regenerative Medicine. In this role she worked closely with industry to develop non-invasive characterisation techniques for application in regenerative medicine. In 2008 Melissa was awarded a 3 year National Physical Laboratory (NPL) Strategic Fellowship. In this post her research work centred on the development of novel acoustic methods to investigate the complex mechanical properties of hydrogels on a mesoscopic scale. Melissa also took a leading role in the development of an ASTM International standard guide on hydrogel characterisation which will assist in the regulation of hydrogel products. This involved co-ordinating a working group containing members from industry, academia and the United States Food and Drug Administration. In 2011 Melissa joined the Institute of Biophysics, Imaging and Optical Science (IBIOS), University of Nottingham to take up the award of an EPSRC Career Acceleration Fellowship to develop a new class of ultrasonic transducer based on self-assembling liposomes. She is also leading a major research activity in IBIOS centred on label-free, multi-modal optical microscopy for characterisation of live cells in culture. The downstream applications of this novel optical imaging platform lie in cellular therapies used in Regenerative Medicine. Significant findings from this work include acquisition of label-free images of live cells with unprecedented high spatial resolution. The multi-modal aspect of the instrument has also enabled early prediction of stem cell differentiation which is of tremendous value to not only those developing new therapies but also in relation to end product regulatory safety and efficacy tests. In 2014 Melissa was invited to take the role of Deputy Director and Engineering lead of IBIOS. In August 2015 Melissa was appointed Professor of Biomedical Imaging in the Institute for Science and Technology in Medicine, Keele University. Here she continues to pursue research in the discovery and development of optical, ultrasound and opto-acoustic techniques for non-invasive monitoring of lipid membranes, cells, tissue and biomaterials.

Prof Low left Kuala Lumpur, Malaysia for Dunedin, New Zealand in early 90’s to pursue his dream as a scientist. Having spent wonderful undergraduate and postgraduate years at the Department of Biochemistry, University of Otago, he joined IMCB, Singapore and then NUS, trying to figure out what exactly make cells work. Amazing as it is, we are still far from understanding the intricacy underlying these processes. Trained as a biochemist, practising mainly as a cell biologist now, and with exciting arrays of multi-disciplinary tools, his team and collaborators aim to systematically unravel some of the uncharted paths, and are ready to expect the unexpected.

Dr. Henry, Yu-Keung MOK is currently an Associate Professor and Deputy Head (Undergraduate) of the Department of Biological Sciences, Faculty of Science in National University of Singapore (NUS). He obtained his PhD at the University of Cambridge in 1996 on the study of folding and NMR structure of the DNA binding domain of the human papillomavirus E2 protein. At NUS, his expertise is in determining the structural/functional relationship of proteins involved in human diseases using both NMR and X-ray crystallography. His group has determined structures of allergens from dust mites and cockroaches that lead to understanding of the disease like asthma and atopic dermatitis. The group also worked on structures of chaperones, translocators and effectors from the type III and VI secretion system to elucidate the pathogenic mechanism of bacterial infection. Recently, the group has awarded a Ministry of Education Tier 3 grant to work on how salivary proteins from mosquitoes could enhance the transmission of dengue viruses.

Dr. Chung is currently a full professor of Biology at Duke Kunshan University. He received his BS and MS in Zoology from Seoul National University in South Korea and Ph.D. in Cell Biology from Duke University. He did postdoctoral training in Molecular Genetics at University of California at San Diego and worked as an Assistant Project Scientist at UCSD. Dr. Chung joined the faculty of the Department of Pharmacology at Vanderbilt University School of Medicine in 2001 where he was promoted to a tenured Associate Professor. In 2014, Dr. Chung moved to Tianjin University in China where he was a Full Professor. His current research focuses on examining the role of microglia activation/chemotaxis in neuro-inflammation during the progression of neurodegenerative diseases. His research in directed cell migration has significant impacts in numerous important areas of work including cancer, Alzheimer’s, depression, and immunological disorders. He was a recipient of the Special Fellow Award from the Leukemia and Lymphoma Society. His research was supported by funding from NIH and AHA (USA) and NSFC (China). He has taught undergraduate, graduate, and medical students in courses that span the wide range including Introductory Biology, Cell Biology, Molecular Genetics, Scientific Communications, and Neuropharmacology.

We will update it soon

We will Update it soon